Your browser doesn't support javascript.
loading
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Godman, Brian; Shrank, William; Wettermark, Bjorn; Andersen, Morten; Bishop, Iain; Burkhardt, Thomas; Garuolienè, Kristina; Kalaba, Marija; Laius, Ott; Joppi, Roberta; Sermet, Catherine; Schwabe, Ulrich; Teixeira, Inês; Tulunay, F Cankat; Wendykowska, Kamila; Zara, Corinne; Gustafsson, Lars L.
Afiliação
  • Godman B; Institute for Pharmacological Research 'Mario Negri', Via Giuseppe La Masa 19, 20156 Milan, Italy. godman@marionegri.it.
  • Shrank W; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool L69 7ZH, UK. godman@marionegri.it.
  • Wettermark B; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. godman@marionegri.it.
  • Andersen M; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, suite 3030. Boston, MA 02120, USA. wshrank@partners.org.
  • Bishop I; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. bjorn.wettermark@ki.se.
  • Burkhardt T; Centre for Pharmacoepidemiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden. bjorn.wettermark@ki.se.
  • Garuolienè K; Centre for Pharmacoepidemiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden. morten.andersen@ki.se.
  • Kalaba M; Information Services Healthcare Information Group, NHS Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK. iain.bishop@nhs.net.
  • Laius O; Hauptverband der Österreichischen Sozialversicherungsträger, Kundmanngasse 21, A-1031 Wien, Austria. thomas.burkhardt@hvb.sozvers.at.
  • Joppi R; Faculty of Medicine, Department of Pathology, Forensic Medicine and Pharmacology, University of Vilnius, M. K. Ciurlionio g. 21/27, Vilnius, Lithuania. kristina.garuoliene@vlk.lt.
  • Sermet C; Medicines Reimbursement Department, National Health Insurance Fund, Kalvariju Str. 147, Vilnius, Lithuania. kristina.garuoliene@vlk.lt.
  • Schwabe U; Republic Institute for Health Insurance, Jovana Marinovica 2, 11000 Belgrade, Serbia. marija.kalaba@rzzo.rs.
  • Teixeira I; State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia. ott.laius@ravimiamet.ee.
  • Tulunay FC; Institute for Pharmacological Research 'Mario Negri', Via Giuseppe La Masa 19, 20156 Milan, Italy. roberta.joppi@ulss20.verona.it.
  • Wendykowska K; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy. roberta.joppi@ulss20.verona.it.
  • Zara C; IRDES, 10, rue Vauvenargues, 75018 Paris, France. sermet@irdes.fr.
  • Gustafsson LL; University of Heidelberg, Institute of Pharmacology, D-69120 Heidelberg, Germany. ulrich.schwabe@pharma.uni-heidelberg.de.
Pharmaceuticals (Basel) ; 3(8): 2470-2494, 2010 Aug 05.
Article em En | MEDLINE | ID: mdl-27713363
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2010 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2010 Tipo de documento: Article País de afiliação: Itália